MedTrace Logo

Patient Directed Intervention to Improve the Quality of Life for Patients With Soft Tissue Sarcoma

NCT02204111 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2018-11-08

No results posted yet for this study

Summary

The primary objective of the study is to compare quality of life (QoL) between patients suffering from soft tissue sarcoma, receiving a multidimensional intervention with those receiving standard treatment.

Conditions

  • Soft Tissue Sarcoma

Interventions

OTHER

Intervention

Individualized treatment proposals (e.g. pain therapy, physiotherapy, psychological contact) from expert consensus, based on Patient Reported Outcomes

Sponsors & Collaborators

  • GWT-TUD GmbH

    lead OTHER

  • PharmaMar

    collaborator INDUSTRY

Principal Investigators

  • Markus Schuler, Dr. med. · University Hospital Carl Gustav Carus, Dresden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204111 on ClinicalTrials.gov